Karl-Otto Dubowy Selected Research

Ninhydrin

12/2020

Method comparison of HPLC-ninhydrin-photometry and UHPLC-PITC-tandem mass spectrometry for serum amino acid analyses in patients with complex congenital heart disease and controls.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karl-Otto Dubowy Research Topics

Disease

2	Heart Failure 01/2020 - 01/2020
2	Ventricular Tachycardia 02/2016 - 10/2015
2	Tetralogy of Fallot (Fallot Tetralogy) 10/2015 - 11/2013
1	Congenital Heart Defects (Congenital Heart Defect) 12/2020
1	Cardiomyopathies (Cardiomyopathy) 11/2020
1	Inflammation (Inflammations) 01/2020
1	Pulmonary Hypertension 05/2016
1	Vascular Diseases (Vascular Disease) 05/2016
1	Eisenmenger Complex (Eisenmenger's Syndrome) 09/2014

Drug/Important Bio-Agent (IBA)

2	Amino Acids FDA Link 12/2020 - 01/2020
2	Oxygen (Dioxygen)IBA 10/2015 - 11/2013
1	NinhydrinIBA 12/2020
1	Proteins (Proteins, Gene)FDA Link 11/2020
1	acylcarnitineIBA 01/2020
1	Phospholipids (Phosphatides)FDA LinkGeneric 01/2020
1	Clostridium perfringens epsilon-toxinIBA 10/2015
1	pro-brain natriuretic peptide (1-76)IBA 09/2014
1	Bosentan (Tracleer)FDA Link 09/2014
1	Carbon DioxideIBA 11/2013

Therapy/Procedure

2	Therapeutics 05/2016 - 09/2014
1	Ambulatory Care (Outpatient Care) 05/2016
1	Resuscitation 02/2016